| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 148,578 | 128,647 | 153,285 | 185,936 | | Cost of Revenue | 88,479 | 75,922 | 97,430 | 107,384 | | | Gross Profit | 60,099 | 52,725 | 55,855 | 78,552 | | | Operating Expenses | | Research Development | 5,679 | 5,692 | 6,523 | 6,033 | | Selling General and Administrative | 49,011 | 45,460 | 71,710 | 56,074 | | Non Recurring |
-
| 43,363 | 17 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,409 | (41,790) | (22,395) | 16,445 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 424 | 13 | (4) | 2,770 | | Earnings Before Interest And Taxes | 5,833 | (41,777) | (22,399) | 19,215 | | Interest Expense | 912 | 652 | 1,117 | 1,142 | | Income Before Tax | 4,921 | (42,429) | (23,516) | 18,073 | | Income Tax Expense | 1,914 | (683) | (6,627) | 4,088 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,007 | (41,746) | (16,889) | 13,985 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,007 | (41,746) | (16,889) | 13,985 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,007 | ($41,746) | ($16,889) | $13,985 |
|
0.02% Nasdaq 
0.03%
Income Statement
